FundedIQ
Data

Konekti

We help process analysts to prepare data fast and easy, doubling their impact.

www.getkonekti.io Eindhoven, The Netherlands 1-10 employees
Total raised
$1.4M
Rounds
1
Latest
Seed
Oct 2025

We help process analysts to prepare data fast and easy, doubling their impact.

Konekti has raised $1.4M across 1 round. Its most recent round was a Seed of $1.4M in Oct 2025. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Oct 30, 2025
Seed
$1.4M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Konekti is featured in

Similar companies

Lucent

Lucent creates behavioral datasets for frontier labs grounded in real-world product usage.

Pre-Seed $1.3M
DataJoint

DataJoint makes science reproducible -- and productive. Our platform operates computational pipelines and automates data governance.

Seed $4.9M
Adelphi Data

Adelphi Data is building the technology for data sharing in the intelligence community.

Venture - Series Unknown $7.1M
Overmind

Predict fallout caused by infrastructure code changes

Seed $6.0M
ProQR Therapeutics

ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.

Series Unknown $59.2M
UniQure

uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Gene therapy offers the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration. Our first product, Glybera, was approved by the European Commission in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. We are also developing a pipeline of additional adeno-associated virus (AAV)-based gene therapies through multiple collaborations. We develop our gene therapies using our innovative, modular technology platform, including our proprietary manufacturing process. We initially are focused on orphan diseases but believe that we will also be able to develop gene therapies targeting chronic and degenerative diseases that affect larger populations.

Series Unknown $259M
Droppie

Droppie is a recycling company that makes recycling easy and more accessible for consumers. The app is designed to help consumers recycle more effectively by offering small rewards for their recycled materials.

Seed $4.8M
Schunk Xycarb Technology

Schunk Xycarb Technology develops and manufactures high-tech quartz, ceramic, and graphite consumable parts utilized in semiconductor wafer processing equipment. The company provides specialized engineering and coating services to help global chipmakers optimize performance during advanced manufacturing processes.

Series Unknown $3.9M
Vertoro

Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels.

Series B $11.5M
Vivici

Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers.

Series Unknown $11.5M
OurMind

OurMind is a HealthTech startup that builds generative AI tools to automate administrative and clinical workflows for healthcare professionals. Its flagship software captures real-time doctor-patient conversations across 90 languages and instantly converts them into structured medical notes. Built by medical providers and co-owned by dozens of specialists, the platform saves clinicians roughly 2 to 3 hours of paperwork daily to combat industry-wide burnout.

Seed $2.4M
Agensi

The trust and distribution layer for AI agents

Pre-Seed $120k
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.